In this week's episode of the Gaining Health podcast, host Karli Burridge discusses the SELECT Trial and the results for implementation into obesity medicine practice.  The improvements in cardiovascular disease and obesity management through semaglutide (GLP-1 receptor agonist) medication treatment have now also been shown in patients without diabetes.  This landmark study is a step closer to victory for the obesity treatment community and patients struggling with obesity management.https://www.nejm.org/doi/full/10.1056/NEJMoa2307563Support the showThe Gaining Health Podcast will release a new episode every Wednesday, alternating between interviews with experts and "What's Up Wednesday" scientific updates.For a roadmap for developing an obesity program, editable forms and templates, patient education materials, and more, check out Gaining Health If you are loving this podcast, please consider supporting us on Patreon